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Generation and characterization 
of a mouse line for monitoring 
translation in dopaminergic 
neurons
Joseph D. Dougherty1,2
We developed a mouse line targeting midbrain dopamine neurons for Translating Ribosome Affinity 
Purification(TRAP). Here, we briefly report on the basic characterization of this mouse line including 
confirmation of expression of the transgene in midbrain dopamine neurons and validation of its 
effectiveness in capturing mRNA from these cells. We also report a translational profile of these neurons 
which may be of use to investigators studying the gene expression of these cells. Finally, we have 
provided the line to Jackson Laboratories for distribution and use in future studies.
Dopamine(DA) is an important neurotransmitter in the central nervous system. Though produced in limited cell 
populations throughout the mouse brain1, dopaminergic axons project widely throughout the nervous system, 
modulating a wide variety of circuits. Most notably, highly robust projections from the dopaminergic cells of the 
substantia nigra(SN) and ventral tegmental areas(VTA) to the striatum are essential for modulating behavior. 
Projections from VTA neurons to the nucleus accumbens have long been known to play a fundamental role in 
reward and are thought to be the common convergent pathway for all drugs of abuse2, while the dorsal-lateral 
striatum has a greater role in motor behavior3. Finally, both populations of neurons, but especially the SN, are vul-
nerable to genetic or environmental insults that result in their degeneration in patients with Parkinson’s disease. 
Thus, DA producing neurons have been a focus of intense scientific interest for decades with a deep cannon of 
accumulated knowledge about their morphology, projections, function, and physiology.
To enable study of translation specifically in DA producing cells of the mouse brain, we developed a transgenic 
mouse line expressing a ribosomal protein fused to GFP, eGFP/RPL10A, in DA neurons to permit Translating 
Ribosome Affinity Purification(TRAP) from these cells. Here we provide characterization of the expression of this 
line and validation of its ability to harvest mRNA from midbrain DA neurons. This line has now been distributed 
to Jackson laboratories(Stock# 030272) and should provide a resource for investigators interested in studying 
transcription and translation in these cells.
Results
We generated two transgenic mouse lines to target this population of neurons. We first used a bacterial artificial 
chromosome(BAC) containing the tyrosine hydroxylase (Th) gene, a key enzyme in the synthesis of DA and 
norepinephrine which has traditionally been used as a marker of these cells, by replacing the coding sequence 
with the eGFP/RPL10a transgene. Characterization of eGFP expression in this mouse line showed some robust 
expression in the regions where DA neurons were known to be found, but also ectopic expression in TH negative 
populations in hypothalamus, striatum, and even sparse cells in cortex. There was also labeling in a subset of 
Purkinje neurons in the cerebellum, though this later pattern was somewhat consistent with some prior immuno-
histochemical data reporting TH expression in Purkinje cells4 and suggests that the enzyme has purposes in the 
CNS beyond the synthesis of DA and norepinephrine. It is also possible that this discrepancy reflects some level 
of difference between transcription and translation of the Th gene, and is consistent with a recent report of more 
widespread expression of Th mRNA than protein5. Although a pilot study demonstrated that TRAP could harvest 
RNA from midbrain dopaminergic cells(data not shown), concerns about ectopic expression precluded further 
pursuit of this line. Thus, these first mice lacked specificity for DA producing neurons.
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Therefore we next tested a BAC containing the Slc6a3 gene, coding for the protein commonly known as the 
DA transporter(DAT). Immunohistochemical characterization of this mouse line revealed robust expression 
of eGFP/RPL10a in midbrain DA producing neuronal populations (Fig. 1A). Colabeling with TH antibodies 
revealed that TH positive neurons were consistently eGFP positive in these populations (Fig. 1B). We then iso-
lated ribosome bound RNA from adult midbrain DA neurons and measured gene expression by microarray. 
Independent replicates showed high reproducibility (Fig. 2A). In addition, TRAP RNA was markedly different 
from parallel profiles of input RNA purified from the whole midbrain dissection (Fig. 2B). Specifically, a variety of 
known DA neuronal markers including Th (48 fold), Slc6a3 (6.8 fold), and Ntsr1(19.9 fold), were all significantly 
enriched in the TRAP sample (p < 0.003, p < 0.005, p < 0.05, respectively; LIMMA, with FDR correction). We 
believe the relatively lower enrichment of Slc6a3 likely represents saturation of the microarray probeset for this 
transcript in the TRAP sample, as there is no a priori reason to assume it should be substantially less enriched 
than Th, and the raw intensity values for the TRAP Slc6a3 probesets are in the top 0.05% of all probesets on 
the array. Non-neuronal ‘negative control’ transcripts were moderately depleted at a level typical of this TRAP 
protocol6.
As a final validation of the new mouse reagent, we defined the set of most SN/VTA enriched transcripts 
(Table 1). Examination of a subset of these genes with publically available coronal in situ hybridization data 
confirmed high levels of expression for all in a pattern consistent with midbrain DA neurons (Fig. 3). Likewise, 
an analysis of enrichment of particular biological and molecular processes of the top enriched (pSI < 0.005) tran-
scripts revealed enrichment of categories for “Ion Channel Activity” (p < 4.5E-5, Benjamini Hochberg corrected 
p-value), driven by transcripts such as Kcnd3, Scn3a, and Chrna6, “Dopamine Biosynthetic Process” (p < 1.3E-
3), driven by transcripts for enzymes such as Th, Gch, and Ddc7, and “Dopaminergic Neuron Differentiation” 
(p < 1.2E-2), driven by known master regulators such as En1, Foxa2, Nr4a2, Pitx3, and Lmx1b8, consistent with 
identification of transcripts enriched in midbrain DA neurons.
Discussion
We report here the generation and characterization of a mouse line capable of translationally profiling midbrain 
dopamine-transporter expressing neurons. We show robust expression in all midbrain Th positive neurons, and 
confirm the ability of the mouse line to enable translational profiling. Thus, the mouse line should be useful 
to investigate ribosome bound transcripts in these neurons both at baseline, and in response to experimental 
manipulations, such as stimulation by drugs of abuse. We have also recently adapted a procedure for nuclear RNA 
purification from TRAP mouse lines9, so both nuclear transcription and cytoplasmic translation are in theory 
accessible using this line, and others have shown that the same basic approach can be applied to study the epige-
netic profile of specific neuronal cell types10.
It is an interesting question as to why the Th bacTRAP line showed expression outside of TH positive cells. 
In the modified BAC designed to express eGFP/RPL10A in lieu of TH, the eGFP/RPL10a transgene sequence, 
followed by a strong polyA signal, is inserted at the translational start site of the Th gene. Thus, the transgene 
will co-opt the promoter/enhancers of the Th gene, due to the polyA signal but not the 3′ UTR. Thus, to the 







Figure 1. Anatomical confirmation of eGFP/RPL10A expression in midbrain dopamine neurons. (A) 
Anti-GFP immunohistochemistry shows regional expression of eGFP/RPL10A in neurons, consistent with 
expression in midbrain dopamine cells. (B) Immunofluorescence colocalization confirms expression in all Th 
positive neurons of the midbrain and only in Th positive neurons.
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‘ectopic’ populations, one would expect to detect eGFP/RPL10a protein in cells where TH protein is absent. Such 
translational regulation might also explain why many Th Cre lines, including knock-ins and transgenics, show 
recombination in Th negative cells11.
We also note that the new Slc6a3 TRAP line is distinct from the one recently used to successfully profile mid-
brain DA neurons in an MPTP Parkinson’s model12. Both lines were generated by modifying the same initial BAC, 
however the current line was initiated on the FVB strain and subsequently backcrossed to C57BL6/J mice, while 
the other line was directly generated on C57 mice from Charles River. Thus there will be modest strain differences 
between the two because of the different sources of C57 mice and any remaining introgressed FVB alleles in link-
age with the transgene. Also, as they are separate integrants, they are expected to differ in transgene copy number 
and location. However, the line reported here is the exact line used to successfully profile embryonic midbrain 
DA neurons5. As the current line is being released by Jackson labs, we have provided this brief report to provide 
details of the generation and characterization of the line for future investigators, especially as minor differences 
between expected and actual strain or copy number could influence experimental results. Also, though they were 
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Figure 2. Slc6a3 JD1640 TRAP line allows for reproducible and specific purification or mRNAs from midbrain 
dopamine neurons. (A) Illustration of the bacTRAP method. Specific cell types are driven to express a GFP 
tagged ribosomal protein(RPL10A) using a cell type specific promoter in engineered from a bacterial artificial 
chromosome (BAC). After validation of the line, midbrains can be homogenized and lysates incubated with 
anti-GFP coated magnetic beads to enrich for mRNA from DA neurons. (B) Two microarray experiments on 
independent pools of Slc6a3 JD1640 TRAP mice result in reproducible mRNA expression (Pearson r > 0.98). 
(C) Comparison of TRAP purified from mRNA from Slc6a3 JD1640 TRAP to total RNA of midbrain shows 
robust enrichment of transcripts known to be expressed in dopaminergic neurons (blue), and moderate 
depletion of known glial genes (red). Lines in A and B show 2-fold enrichment or depletion (Pearson r > 0.90). 
(D) Hierarchical clustering of a variety of TRAP microarray datasets based on all transcripts with a pSI < 0.001 
in any cell type reveals midbrain dopamine neurons(blue) are most similar to other neuromodulatory cells in 
enriched gene expression.
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generated independently of GENSAT, neuroanatomical data for this and other published bacTRAP lines are now 
also being hosted at the GENSAT website for the convenience of the field.
The translational profile of DA neurons provided here may also be of use to investigators interested in these 
cells. For example, it has recently been noted that midbrain DA neurons can co-release the neurotransmitter 
GABA13, yet do not appear to contain the traditional GABA synthesizing enzymes GAD65 and GAD6714 coded 
ProbeID Mid Slc6a3 FC adj.P pSI Symbol EntrezID Long Name
1418601_at 7.9 2516.5 317.5 8.2E-04 1.9E-06 Aldh1a7 26358 aldehyde dehydrogenase family 1, subfamily A7
1448213_at 80.9 4191.1 51.8 9.6E-03 1.9E-06 Anxa1 16952 annexin A1
1438861_at 148.2 1517.3 10.2 3.2E-03 1.9E-06 Bnc2 242509 basonuclin 2
1455416_at 51.8 1630.8 31.5 4.1E-03 1.9E-06 C130021I20Rik 100504399 Riken cDNA C130021I20 gene
1446877_at 39.5 498.3 12.6 1.5E-02 1.9E-06 C230014O12Rik 329387 RIKEN cDNA C230014O12 gene
1421203_at 72.9 785.2 10.8 3.0E-02 1.9E-06 Chrna4 11438 cholinergic receptor, nicotinic, alpha polypeptide 4
1442035_at 7.4 309.3 41.6 3.3E-03 1.9E-06 Chrna5 110835 cholinergic receptor, nicotinic, alpha polypeptide 5
1450427_at 121.4 6196.6 51.1 5.2E-03 1.9E-06 Chrna6 11440 cholinergic receptor, nicotinic, alpha polypeptide 6
1418617_x_at 12.4 302.4 24.4 2.7E-03 1.9E-06 Clgn 12745 Calmegin
1433715_at 114.1 1516.6 13.3 4.4E-02 1.9E-06 Cpne7 102278 copine VII
1430591_at 4.6 82.1 17.9 4.5E-06 1.9E-06 Ddc 13195 dopa decarboxylase
1426215_at 2917.1 29921.0 10.3 1.3E-02 1.9E-06 Ddc 13195 dopa decarboxylase
1449939_s_at 18.5 1399.6 75.8 1.3E-02 1.9E-06 Dlk1 13386 delta-like 1 homolog (Drosophila)
1418618_at 12.8 1092.8 85.2 4.9E-03 1.9E-06 En1 13798 engrailed 1
1455872_at 24.3 3072.6 126.7 1.3E-02 1.9E-06 Fam167a 219148 family with sequence similarity 167, member A
1424695_at 4.7 314.3 67.5 3.2E-05 1.9E-06 Fam210b 67017 family with sequence similarity 210, member B
1421677_at 4.9 80.4 16.5 1.6E-02 1.9E-06 Fgf20 80857 fibroblast growth factor 20
1421855_at 23.2 289.9 12.5 2.9E-02 1.9E-06 Fgl2 14190 fibrinogen-like protein 2
1418496_at 239.6 6050.6 25.3 2.4E-02 1.9E-06 Foxa1 15375 forkhead box A1
1422833_at 25.7 705.7 27.5 1.2E-03 1.9E-06 Foxa2 15376 forkhead box A2
1441384_at 7.1 140.8 19.7 1.3E-03 1.9E-06 Gadl1 73748 glutamate decarboxylase-like 1
1429692_s_at 78.7 3291.0 41.8 1.4E-02 1.9E-06 Gch1 14528 GTP cyclohydrolase 1
1419593_at 5.8 91.7 15.8 7.3E-03 1.9E-06 Greb1 268527 gene regulated by estrogen in breast cancer protein
1436370_at 12.0 1766.4 147.8 7.0E-03 1.9E-06 Gucy2c 14917 guanylate cyclase 2c
1454783_at 12.1 737.0 60.8 1.0E-02 1.9E-06 Il13ra1 16164 interleukin 13 receptor, alpha 1
1436465_at 68.4 996.4 14.6 4.7E-02 1.9E-06 Klhl1 93688 kelch-like 1
1449241_at 102.2 1395.2 13.7 1.9E-02 1.9E-06 Klhl1 93688 kelch-like 1
1441729_at 68.7 846.1 12.3 1.1E-02 1.9E-06 Lmx1b 16917 LIM homeobox transcription factor 1 beta
1453225_at 6.2 120.9 19.5 6.9E-02 1.9E-06 Ndnf 68169 neuron-derived neurotrophic factor
1450750_a_at 145.4 3136.9 21.6 4.6E-03 1.9E-06 Nr4a2 18227 nuclear receptor subfamily 4, group A, member 2
1420799_at 403.7 8036.3 19.9 3.1E-02 1.9E-06 Ntsr1 18216 neurotensin receptor 1
1449917_at 4.6 195.7 42.6 3.5E-04 1.9E-06 Pitx3 18742 paired-like homeodomain transcription factor 3
1421359_at 4.6 427.4 93.2 1.2E-02 1.9E-06 Ret 19713 ret proto-oncogene
1436359_at 2072.3 24126.0 11.6 7.8E-03 1.9E-06 Ret 19713 ret proto-oncogene
1437079_at 322.1 11457.0 35.6 2.6E-02 1.9E-06 Slc18a2 214084 solute carrier family 18 (vesicular monoamine), member 2
1451139_at 4.6 190.1 41.1 9.8E-03 1.9E-06 Slc39a4 72027 solute carrier family 39 (zinc transporter), member 4
1455442_at 5.2 246.1 47.5 1.7E-02 1.9E-06 Slc6a19 74338 solute carrier family 6 (neurotransmitter transporter), member 19
1427919_at 13.1 347.2 26.6 1.0E-02 1.9E-06 Srpx2 68792 sushi-repeat-containing protein, X-linked 2
1437190_at 7.5 126.4 16.8 4.8E-03 1.9E-06 Styk1 243659 serine/threonine/tyrosine kinase 1
1449816_at 7.5 172.4 23.0 1.6E-05 1.9E-06 Sult5a1 57429 sulfotransferase family 5A, member 1
1422955_at 34.7 1163.7 33.6 3.2E-02 1.9E-06 Syt17 110058 synaptotagmin XVII
1437029_at 79.5 1777.9 22.4 5.0E-02 1.9E-06 Tacr3 21338 tachykinin receptor 3
1420546_at 356.1 17293.2 48.6 2.1E-03 1.9E-06 Th 21823 tyrosine hydroxylase
1445371_at 8.8 237.1 26.9 5.8E-03 1.9E-06 Tmem207 100043057 transmembrane protein 207
1449431_at 7.2 431.1 60.0 1.2E-05 1.9E-06 Trpc6 22068 transient receptor potential cation channel, subfamily C, member 6
1425163_at 8.2 184.6 22.5 9.4E-04 1.9E-06 AI661453 224833 expressed sequence AI661453
1460425_at 4.6 154.2 33.6 2.3E-04 1.9E-06 1700001C19Rik 75462 RIKEN cDNA 1700001C19 gene
Table 1. Probesets with >10 fold enrichment, p < 0.01, and pSI < 0.10e-6. ProbeID: Affymetrix Probe ID, Mid, 
Slc6a3: Expression level in midbrain Input RNA and Slc6a3 TRAP RNA, respectively. FC: ‘Fold-Change’ value 
of Slc6a3/Mid. adj.P: LIMMA FDR adjusted p-value for Slc6a3 vs Mid. pSI: Specificity index statistic p-value, 
when Slc6a3 is compared to other TRAP samples (Fig. 2C). Symbol: Official gene symbol. EntrezID:Entrez Gene 
ID. Long Name: Official gene name.
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for by the genes Gad1 and Gad2. Our microarray data is consistent with this expression pattern, showing robust 
depletion of these two genes from the TRAP sample (e.g. Gad1 6588 arbitrary expression units in the input RNA, 
and only 2396 in the TRAP, with this remaining TRAP signal likely reflecting non-specific background). However, 
the Gad paralog GadL1 is 19 fold enriched in midbrain DA neurons (p < 0.002), though likely expressed only at 
low levels (absolute expression level: 140.8). Although normally thought to be involved in synthesis of Carnitine 
or Taurine rather than GABA15, 16, several unstudied splice isoforms are present in the UCSC genome browser. If 
any of the unstudied splice isoforms do produce GABA this might contribute to GABA neurotransmission from 
DA cells. Thus, to enable investigators to query our findings for additional insights, the complete analyzed data is 
provided as Supplemental Table 1.
Methods
Generation of mouse line. All procedures involving animals were approved by the Animal Studies 
Committee of Washington University in St. Louis and the Rockefeller University Institute Animal Care and Use 
Committee. All methods were carried out in accordance with relevant guidelines and regulations. A BAC RP24-
269I17, was modified as described17, to insert the TRAP construct EGFP/RPL10A18 into the translation start site 
of the Slc6a3 gene. Recombination was confirmed by Southern blot. Modified BAC DNA was purified by CsCl 
centrifugation and injected into fertilized FVB oocytes as described19. Founder mice were bred to C57BL6/j mice 
for subsequent generations. Mice were maintained as trans-heterozygotes and transgene carrying pups were iden-
tified at each generation by genotyping tail clip DNA for GFP.
Translating Ribosome Affinity Purification. Five adult mice per replicate were euthanized with CO2, 
and midbrains were dissected in ice cold buffer in the presence of cyclohexamide to stall translation. TRAP was 
conducted as described20. Parallel input fractions were collected from each replicate as a measure of whole mid-
brain tissue RNA composition. RNA quantity and quality were determined with a Nanodrop 1000 spectropho-
tometer and Agilent 2100 Bioanalyzer with PicoChip reagents. All RINs were above 7. For each replicate, up to 10 
ng of total RNA was amplified with the Affymetrix two-cycle amplification kit and hybridized to Affymetrix 430 
2.0 microarrays according to the manufacturer’s instructions, and data were processed in R as described6, using 
GCRMA for normalization and identification of specific and enriched genes using the pSI package6 with default 




Figure 3. Examples of highly enriched transcripts in midbrain dopamine neurons. Shown are the first 9 genes 
of Table 1 with coronal in situ hybridization patterns available in the Allen Brain Atlas25. All show a regional 
pattern consistent with high and or/specific enrichment in midbrain dopamine neurons. Some (e.g. Anxa1) 
appear to only be expressed in a subset of the neurons, while others (Cpne) are highly expressed in SN/VTA but 
also show expression in additional populations. Images are from http://mouse.brain-map.org.
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Anatomical analysis. For immunohistochemistry(IHC), mice were euthanized then perfused transcardially 
with PBS, followed by PBS with 4% paraformaldehyde. Brains were dissected, cryoprocted with 30% sucrose in 
PBS then processed MultiBrain Technology (NSA, NeuroScience Associates, Knoxville, TN) for DAB IHC with a 
1:75,000 dilution of Goat anti-EGFP serum according to the Vectastain elite protocol (Vector Labs, Burlingame, 
CA). Serial sections were digitized with a Zeiss Axioskop2 microscope at 10× magnification.
For immunofluorescent studies, brains were prepared as above, frozen and sectioned to 40 uM on a crytostat, 
and stored in PBS with 0.1% azide until use. Sections were blocked with 5% normal donkey serum and 0.25% tri-
ton and then incubated with Chicken anti-GFP(Abcam) and Mouse anti-Th (Chemicon) followed by appropriate 
Alexa dye-conjugated secondary antibodies (Invitrogen, Carlsbad, CA). Images were acquired as Z stacks (2 μm 
sections) with a Zeiss Inverted LSM 510 confocal microscope.
For Allen Brain Atlas images of Fig. 3, we selected for presentation the first 9 available coronal in situ hybrid-
ization image sets, alphabetically, from those transcripts with > 10 fold enrichment, p < 0.01, and pSI < 0.10e-6 
(Table 1).
Data Availability. Analyzed data are available as Supplemental Table 1. Raw data are available at GEO: 
GSE99927.
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